• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在多系统电子健康记录数据库中检测到的肌肉减少症、衰弱症和恶病质患者。

Sarcopenia, frailty and cachexia patients detected in a multisystem electronic health record database.

作者信息

Moorthi Ranjani N, Liu Ziyue, El-Azab Sarah A, Lembcke Lauren R, Miller Matthew R, Broyles Andrea A, Imel Erik A

机构信息

Department of Medicine, Indiana University School of Medicine, 1120 West Michigan Street CL 365, Indianapolis, Indiana, 46202-5111, USA.

Department of Biostatistics, Indiana University School of Public Health, Indianapolis, Indiana, 46202, USA.

出版信息

BMC Musculoskelet Disord. 2020 Jul 31;21(1):508. doi: 10.1186/s12891-020-03522-9.

DOI:10.1186/s12891-020-03522-9
PMID:32736613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7395344/
Abstract

BACKGROUND

Sarcopenia, cachexia and frailty have overlapping features and clinical consequences, but often go unrecognized. The objective was to detect patients described by clinicians as having sarcopenia, cachexia or frailty within electronic health records (EHR) and compare clinical variables between cases and matched controls.

METHODS

We conducted a case-control study using retrospective data from the Indiana Network for Patient Care multi-health system database from 2016 to 2017. The computable phenotype combined ICD codes for sarcopenia, cachexia and frailty, with clinical note text terms for sarcopenia, cachexia and frailty detected using natural language processing. Cases with these codes or text terms were matched to controls without these codes or text terms matched on birth year, sex and race. Two physicians reviewed EHR for all cases and a subset of controls. Comorbidity codes, laboratory values, and other coded clinical variables were compared between groups using Wilcoxon matched-pair sign-rank test for continuous variables and conditional logistic regression for binary variables.

RESULTS

Cohorts of 9594 cases and 9594 matched controls were generated. Cases were 59% female, 69% white, and a median (1st, 3rd quartiles) age 74.9 (62.2, 84.8) years. Most cases were detected by text terms without ICD codes n = 8285 (86.4%). All cases detected by ICD codes (total n = 1309) also had supportive text terms. Overall 1496 (15.6%) had concurrent terms or codes for two or more of the three conditions (sarcopenia, cachexia or frailty). Of text term occurrence, 97% were used positively for sarcopenia, 90% for cachexia, and 95% for frailty. The remaining occurrences were negative uses of the terms or applied to someone other than the patient. Cases had lower body mass index, albumin and prealbumin, and significantly higher odds ratios for diabetes, hypertension, cardiovascular and peripheral vascular diseases, chronic kidney disease, liver disease, malignancy, osteoporosis and fractures (all p < 0.05). Cases were more likely to be prescribed appetite stimulants and caloric supplements.

CONCLUSIONS

Patients detected with a computable phenotype for sarcopenia, cachexia and frailty differed from controls in several important clinical variables. Potential uses include detection among clinical cohorts for targeting recruitment for research and interventions.

摘要

背景

肌肉减少症、恶病质和衰弱具有重叠的特征及临床后果,但往往未被识别。目的是在电子健康记录(EHR)中检测临床医生描述为患有肌肉减少症、恶病质或衰弱的患者,并比较病例组与匹配对照组之间的临床变量。

方法

我们使用来自印第安纳患者护理网络多健康系统数据库2016年至2017年的回顾性数据进行了一项病例对照研究。可计算表型结合了肌肉减少症、恶病质和衰弱的ICD编码,以及使用自然语言处理检测到的肌肉减少症、恶病质和衰弱的临床笔记文本术语。有这些编码或文本术语的病例与没有这些编码或文本术语的对照组进行匹配,匹配因素包括出生年份、性别和种族。两名医生查看了所有病例和一部分对照组的EHR。使用Wilcoxon配对符号秩检验比较连续变量的合并症编码、实验室值和其他编码临床变量,使用条件逻辑回归比较二元变量。

结果

生成了9594例病例和9594例匹配对照组。病例组中女性占59%,白人占69%,年龄中位数(第1、3四分位数)为74.9(62.2,84.8)岁。大多数病例是通过无ICD编码的文本术语检测到的,n = 8285(86.4%)。所有通过ICD编码检测到的病例(共n = 1309)也有支持性文本术语。总体而言,1496例(15.6%)有三种情况(肌肉减少症、恶病质或衰弱)中两种或更多种的并发术语或编码。在文本术语出现情况中,97%用于积极描述肌肉减少症,90%用于恶病质,95%用于衰弱。其余出现情况是术语的消极使用或应用于患者以外的其他人。病例组的体重指数、白蛋白和前白蛋白较低,患糖尿病、高血压、心血管和外周血管疾病、慢性肾病、肝病、恶性肿瘤、骨质疏松症和骨折的比值比显著更高(所有p < 0.05)。病例组更有可能被开具食欲刺激剂和热量补充剂。

结论

通过可计算表型检测出患有肌肉减少症、恶病质和衰弱的患者在几个重要临床变量上与对照组不同。潜在用途包括在临床队列中进行检测,以便为研究和干预确定招募对象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442e/7395344/f378467699f7/12891_2020_3522_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442e/7395344/f378467699f7/12891_2020_3522_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442e/7395344/f378467699f7/12891_2020_3522_Fig1_HTML.jpg

相似文献

1
Sarcopenia, frailty and cachexia patients detected in a multisystem electronic health record database.在多系统电子健康记录数据库中检测到的肌肉减少症、衰弱症和恶病质患者。
BMC Musculoskelet Disord. 2020 Jul 31;21(1):508. doi: 10.1186/s12891-020-03522-9.
2
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients.老年住院患者中肌少症、衰弱、恶病质和营养不良的流行情况及其重叠。
BMC Geriatr. 2019 Apr 27;19(1):120. doi: 10.1186/s12877-019-1115-1.
3
Frailty, sarcopenia, cachexia and malnutrition as comorbid conditions and their associations with mortality: a prospective study from UK Biobank.虚弱、肌少症、恶病质和营养不良作为合并症及其与死亡率的关系:来自英国生物银行的前瞻性研究。
J Public Health (Oxf). 2022 Jun 27;44(2):e172-e180. doi: 10.1093/pubmed/fdaa226.
4
[Frequency of sarcopenia, cachexia, and associated factors in patients with chronic kidney disease in dialysis treatment].[透析治疗的慢性肾脏病患者中肌肉减少症、恶病质及相关因素的发生率]
Nutr Hosp. 2020 Dec 16;37(6):1157-1165. doi: 10.20960/nh.02954.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Effect of Familial Longevity on Frailty and Sarcopenia: A Case-Control Study.家族长寿对虚弱和肌肉减少症的影响:病例对照研究。
Int J Environ Res Public Health. 2023 Jan 14;20(2):1534. doi: 10.3390/ijerph20021534.
7
Beyond Sarcopenia: older adults with type II diabetes mellitus tend to experience an elevated risk of poor dynamic balance-a case-control study.超越肌肉减少症:患有 2 型糖尿病的老年人往往面临动态平衡不佳的高风险——一项病例对照研究。
BMC Geriatr. 2022 Feb 18;22(1):138. doi: 10.1186/s12877-022-02826-w.
8
Cachexia, muscle wasting, and frailty in cardiovascular disease.心血管疾病中的恶病质、肌肉减少症和衰弱。
Eur J Heart Fail. 2020 Dec;22(12):2314-2326. doi: 10.1002/ejhf.2011. Epub 2020 Oct 14.
9
Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features.营养不良、疲劳、虚弱、脆弱、肌肉减少症和恶病质:临床特征重叠。
Curr Opin Clin Nutr Metab Care. 2012 May;15(3):213-9. doi: 10.1097/MCO.0b013e328352694f.
10
Prognostic implications of diagnosing frailty and sarcopenia in vascular surgery practice.在血管外科实践中诊断衰弱和肌少症的预后意义。
J Vasc Surg. 2019 Sep;70(3):892-900. doi: 10.1016/j.jvs.2018.11.025. Epub 2019 Mar 6.

引用本文的文献

1
A Dynamic Time Warping Extension to Consensus Weight-Based Cachexia Criteria Improves Prediction of Cancer Patient Outcomes.基于共识权重的恶病质标准的动态时间规整扩展改善了癌症患者预后的预测。
JCSM Commun. 2025 Jan-Jun;8(1):e107. doi: 10.1002/rco2.107. Epub 2025 Jan 29.
2
Call to Improve Coding of Cancer-Associated Cachexia.呼吁改进癌症相关性恶病质的编码。
JCO Oncol Pract. 2025 Jul;21(7):926-931. doi: 10.1200/OP-24-00781. Epub 2025 Jan 13.
3
Improving Surgical Outcomes for Older Adults with Adoption of Technological Advances in Comprehensive Geriatric Assessment.

本文引用的文献

1
Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis.肌肉减少症与慢性胰腺炎患者的住院率增加和生存率降低有关。
Pancreatology. 2019 Mar;19(2):245-251. doi: 10.1016/j.pan.2019.01.006. Epub 2019 Jan 14.
2
Sarcopenia: revised European consensus on definition and diagnosis.肌少症:定义和诊断的欧洲共识修订版。
Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
3
Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis.
通过采用综合老年评估中的技术进步改善老年人的手术结局
Semin Colon Rectal Surg. 2024 Dec;35(4). doi: 10.1016/j.scrs.2024.101060. Epub 2024 Nov 6.
4
Integrating data-driven and knowledge-driven approaches to analyze clinical notes with structured data for sarcopenia detection.将数据驱动和知识驱动方法与结构化数据相结合,分析临床笔记以检测肌肉减少症。
Health Informatics J. 2024 Oct-Dec;30(4):14604582241300025. doi: 10.1177/14604582241300025.
5
Unleashing frailty from laboratory into real world: A critical step toward frailty-guided clinical care of older adults.从实验室到现实世界释放脆弱性:迈向老年衰弱患者临床护理的关键一步。
J Am Geriatr Soc. 2024 Nov;72(11):3299-3314. doi: 10.1111/jgs.19151. Epub 2024 Aug 21.
6
The use of natural language processing for the identification of ageing syndromes including sarcopenia, frailty and falls in electronic healthcare records: a systematic review.利用自然语言处理技术在电子医疗记录中识别包括肌肉减少症、虚弱和跌倒在内的老年综合征:系统评价。
Age Ageing. 2024 Jul 2;53(7). doi: 10.1093/ageing/afae135.
7
Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data.评估衰弱老年人药物治疗的获益和危害:来自常规医疗保健数据的药物流行病学研究的启示。
Drugs Aging. 2024 Jul;41(7):583-600. doi: 10.1007/s40266-024-01121-0. Epub 2024 Jul 2.
8
Sarcopenia definition, diagnosis and treatment: consensus is growing.肌少症的定义、诊断和治疗:共识正在形成。
Age Ageing. 2022 Oct 6;51(10). doi: 10.1093/ageing/afac220.
9
Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences.急性髓系白血病的恶病质肌肉消耗:具有严重临床后果的沉睡巨人。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):42-54. doi: 10.1002/jcsm.12880. Epub 2021 Dec 8.
肌少症作为老年人住院的预测因素:系统评价和荟萃分析。
BMC Geriatr. 2018 Aug 22;18(1):188. doi: 10.1186/s12877-018-0878-0.
4
The relationship between frailty and polypharmacy in older people: A systematic review.老年人虚弱与多重用药之间的关系:系统评价。
Br J Clin Pharmacol. 2018 Jul;84(7):1432-1444. doi: 10.1111/bcp.13590. Epub 2018 May 3.
5
Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis.睾酮替代治疗的肌肉反应因给药途径而异:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):465-481. doi: 10.1002/jcsm.12291. Epub 2018 Mar 15.
6
Megestrol acetate for cachexia-anorexia syndrome. A systematic review.醋酸甲地孕酮治疗恶病质-厌食症综合征。系统评价。
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):444-452. doi: 10.1002/jcsm.12292. Epub 2018 Mar 14.
7
Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.国际衰弱与肌少症研究特别工作组关于ICD - 10对肌少症临床实践及临床试验影响的报告
J Frailty Aging. 2018;7(1):2-9. doi: 10.14283/jfa.2017.30.
8
The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE).在捷克共和国,没有长期疾病的老年人肌肉无力与医疗保健费用增加有关:来自欧洲健康、老龄化和退休调查 (SHARE) 的结果。
Clin Interv Aging. 2017 Nov 27;12:2003-2007. doi: 10.2147/CIA.S150826. eCollection 2017.
9
Musculoskeletal health and frailty.肌肉骨骼健康与虚弱。
Best Pract Res Clin Rheumatol. 2017 Apr;31(2):145-159. doi: 10.1016/j.berh.2017.11.002. Epub 2017 Nov 20.
10
Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management.缺乏知识以及诊断设备的可及性可能会阻碍肌少症的诊断及其管理。
PLoS One. 2017 Oct 2;12(10):e0185837. doi: 10.1371/journal.pone.0185837. eCollection 2017.